Erlotinib Active Not Recruiting Phase 1 Trials for Head and Neck Carcinoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00954226Erlotinib Prior to Surgery in Patients With Head and Neck Cancer